Marko Maringer
Overview
Explore the profile of Marko Maringer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eigenbrod S, Frick P, Bertsch U, Mitteregger-Kretzschmar G, Mielke J, Maringer M, et al.
PLoS One
. 2017 Dec;
12(12):e0188989.
PMID: 29220360
Prion diseases have been linked to impaired copper homeostasis and copper induced-oxidative damage to the brain. Divalent metal ions, such as Cu2+ and Zn2+, bind to cellular prion protein (PrPC)...
2.
Elamin A, Steinicke S, Oehlmann W, Braun Y, Wanas H, Shuralev E, et al.
PLoS One
. 2017 Oct;
12(10):e0186801.
PMID: 29045498
For clinicians, Pseudomonas aeruginosa is a nightmare pathogen that is one of the top three causes of opportunistic human infections. Therapy of P. aeruginosa infections is complicated due to its...
3.
Alphey M, Pirrie L, Torrie L, Boulkeroua W, Gardiner M, Sarkar A, et al.
ACS Chem Biol
. 2012 Nov;
8(2):387-96.
PMID: 23138692
Glucose-1-phosphate thymidylyltransferase (RmlA) catalyzes the condensation of glucose-1-phosphate (G1P) with deoxy-thymidine triphosphate (dTTP) to yield dTDP-d-glucose and pyrophosphate. This is the first step in the l-rhamnose biosynthetic pathway. l-Rhamnose is...
4.
Schnell R, Oehlmann W, Sandalova T, Braun Y, Huck C, Maringer M, et al.
PLoS One
. 2012 Feb;
7(2):e31133.
PMID: 22359568
The diaminopimelic acid pathway of lysine biosynthesis has been suggested to provide attractive targets for the development of novel antibacterial drugs. Here we report the characterization of two enzymes from...
5.
Bockamp E, Christel C, Hameyer D, Khobta A, Maringer M, Reis M, et al.
J Gene Med
. 2007 Mar;
9(4):308-18.
PMID: 17330923
Background: Conditional gene regulatory systems ensuring tight and adjustable expression of therapeutic genes are central for developing future gene therapy strategies. Among various regulatory systems, tetracycline-controlled gene expression has emerged...
6.
Bockamp E, Antunes C, Maringer M, Heck R, Presser K, Beilke S, et al.
Blood
. 2006 May;
108(5):1533-41.
PMID: 16675709
The stem cell leukemia gene SCL, also known as TAL-1, encodes a basic helix-loop-helix transcription factor expressed in erythroid, myeloid, megakaryocytic, and hematopoietic stem cells. To be able to make...
7.
Barnewitz K, Maringer M, Mitteregger G, Giese A, Bertsch U, Kretzschmar H
Neuroreport
. 2006 Mar;
17(5):527-30.
PMID: 16543819
In normal brains and cultured cells, cellular prion protein (PrP) is partially found as N-terminally truncated fragments, designated C1 and C2. The cleavage of recombinant PrP to a fragment corresponding...
8.
Trost T, Lausch E, Fees S, Schmitt S, Enklaar T, Reutzel D, et al.
Cancer Res
. 2005 Feb;
65(3):840-9.
PMID: 15705882
The receptor tyrosine kinase ERBB2 plays a central role in the development of breast cancer and other epithelial malignancies. Elevated ERBB2 activity is believed to transform cells by transmitting mitogenic...
9.
Bockamp E, Maringer M, Spangenberg C, Fees S, Fraser S, Eshkind L, et al.
Physiol Genomics
. 2002 Dec;
11(3):115-32.
PMID: 12464688
The ability to engineer the mouse genome has profoundly transformed biomedical research. During the last decade, conventional transgenic and gene knockout technologies have become invaluable experimental tools for modeling genetic...